Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2021-09-02 Board/Management Inform…
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Vitrolifes CFO slutar
Board/Management Information Classification · 100% confidence The document is a press release dated September 2, 2021, announcing that the Chief Financial Officer (CFO) of Vitrolife has resigned. This directly concerns a change in senior management personnel. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The content perfectly matches this description.
2021-09-02 Swedish
Change in number of shares and votes in Vitrolife AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a short press release dated July 30, 2021, announcing a 'Change in number of shares and votes' following a board decision to issue 9,645,303 new shares. This directly relates to a change in the company's capital structure (share count). This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not an earnings release, an annual report, or a mere announcement of a report publication (RPA), as it contains the substantive information regarding the capital change itself.
2021-07-30 English
Ändring av antal aktier och röster i Vitrolife AB (publ)
Share Issue/Capital Change Classification · 98% confidence The document is a short press release dated July 30, 2021, announcing a change in the total number of shares and votes following the issuance of 9,645,303 new shares. This directly relates to a change in the company's capital structure (share count). The filing explicitly mentions the obligation to disclose this information under financial instrument trading laws. This fits the definition of 'Share Issue/Capital Change' (SHA) better than a general regulatory filing (RNS) or a financing update (CAP), as it is a specific notification about the resulting share count after an issuance decision.
2021-07-30 Swedish
Vitrolife’s share buyback program completed
Transaction in Own Shares Classification · 99% confidence The document is a press release dated July 19, 2021, explicitly stating that Vitrolife's share buyback program has been completed. It details the number of shares repurchased and the transaction dates. The core subject is the company's activity regarding its own shares (repurchases). This directly corresponds to the definition for 'Transaction in Own Shares' (Code: POS). The document length is relatively short (2548 chars), but it is a complete announcement of the transaction completion, not just a notice that a report is attached, making POS a more specific fit than RPA or RNS.
2021-07-19 English
Vitrolifes återköpsprogram avslutat
Transaction in Own Shares Classification · 99% confidence The document is a press release dated July 19, 2021, titled "Vitrolifes återköpsprogram avslutat" (Vitrolife's share repurchase program concluded). It details the exact number of shares repurchased (52,568) over two specific days (July 15 and July 16, 2021) and confirms the completion of the program. This activity directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). It is not an earnings release, an annual report, or a general regulatory filing, but a specific disclosure about share transactions.
2021-07-19 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'delårsrapport januari-juni 2021' (Interim Report January-June 2021) for Vitrolife AB. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary for the second quarter and the first half of the year. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2021
2021-07-16 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.